MSB 7.69% $1.19 mesoblast limited

Ann: End-Stage Heart Failure Trial Completes Enrollment, page-132

  1. 289 Posts.
    lightbulb Created with Sketch. 93
    Is anyone able to advise with respect to the ongoing phase 3 CHF trial....once it is fully enrolled, when we can expdect results?
    I'm just trying to ascertain the availability of this trial possibly being used as a confirmatory/ registrational trial for the phase 2 LVAD trial.

    Thanks
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.